Science 37 rakes in $40m

Science 37, a provider of decentralized clinical trials, has raised $40 million in funding.

Science 37, a provider of decentralized clinical trials, has raised $40 million in funding. Lux Capital, Redmile Group and PPD Inc led the round with participation from other investors that included Novartis, Amgen, Sanofi Ventures, GV, Glynn Capital, LifeSci Ventures and Mubadala Ventures.

Source: Press Release